Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025

Core Insights - Iovance Biotherapeutics, Inc. will report its fourth quarter and full year 2024 financial results and corporate updates on February 27, 2025 [1] - A live audio webcast will be hosted by management to discuss these results at 4:30 p.m. EST on the same day [2] - The company aims to be a global leader in tumor infiltrating lymphocyte (TIL) therapies for cancer treatment, with a focus on continuous innovation [5] Financial Results and Corporate Updates - The financial results for Q4 and full year 2024 will be disclosed on February 27, 2025 [1] - The live audio webcast for discussing these results will be available for registration [2][4] Upcoming Events - Iovance will participate in TD Cowen's 45th Annual Health Care Conference on March 3, 2025, and Barclays 27th Annual Global Healthcare Conference on March 13, 2025 [8]